Results 41 to 50 of about 462,772 (320)

Association of Mannose-Binding Lectin 2 (mbl2) gene heterogeneity and its serum concentration with osteoporosis in postmenopausal women

Biomolecules & Biomedicine, 2014
The aim of the study was to detect prevalence of MBL2 exon 1 (codons 52, 54 and 57) genetic polymorphism in postmenopausal women in Bosnia and Herzegovina and its possible role as genetic risk factor for susceptibility to occurrence of osteoporosis in ...
Emina Kiseljaković, Sabaheta Hasić, Amina Valjevac, Mirela Mačkić-Đurović, Radivoj Jadrić, Bakir Mehić, Elma Kučukalić-Selimović, Slavka Ibrulj   +7 more
doaj   +1 more source

Denosumab versus romosozumab for postmenopausal osteoporosis treatment

Scientific Reports, 2021
Denosumab and romosozumab, a recently approved new drug, are effective and widely known molecular-targeted drugs for postmenopausal osteoporosis treatment.
Tomonori Kobayakawa, Akiko Miyazaki, M. Saito, Takako Suzuki, Jun Takahashi, Yukio Nakamura   +5 more
semanticscholar   +1 more source

Construction of predictive model for osteoporosis related factors among postmenopausal women on the basis of logistic regression and Bayesian network

Preventive Medicine Reports, 2023
Osteoporosis is a prevalent chronic disease that often goes unnoticed in postmenopausal women. Early identification of risk factors for osteoporosis in postmenopausal women is essential.
Yanqian Wu, Jianqian Chao, Min Bao, Na Zhang, Leixia Wang   +4 more
doaj   +1 more source

Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review

Journal of Orthopaedic Surgery and Research, 2021
Background Biochemical markers of bone turnover (BTMs), such as the bone alkaline phosphatase (bALP), procollagen type I N propeptide (PINP), serum cross-linked C-telopeptides of type I collagen (bCTx), and urinary cross-linked N-telopeptides of type I ...
Filippo Migliorini, N. Maffulli, F. Spiezia, G. Peretti, M. Tingart, R. Giorgino   +5 more
semanticscholar   +1 more source

Identification of the transcriptome signatures and immune-inflammatory responses in postmenopausal osteoporosis

Heliyon
Postmenopausal osteoporosis is the most common type of osteoporosis in women. To date, little is known about their transcriptome signatures, although biomarkers from peripheral blood mononuclear cells are attractive for postmenopausal osteoporosis ...
Pan Gao, Xiaoguang Pan, Shang Wang, Sijia Guo, Zhanying Dong, Zhefeng Wang, Xue Liang, Yan Chen, Fang Fang, Ling Yang, Jinrong Huang, Chenxi Zhang, Conghui Li, Yonglun Luo, Songlin Peng, Fengping Xu   +15 more
doaj   +1 more source

Regulation of enzymatic lipid peroxidation in osteoblasts protects against postmenopausal osteoporosis

Nature Communications
Oxidative stress plays a critical role in postmenopausal osteoporosis, yet its impact on osteoblasts remains underexplored, limiting therapeutic advances.
Qiong-Yi Zhang, Hai-Biao Gong, Manya Jiang, Fu-Jun Jin, Guan Wang, Chang-Yu Yan, Xiang Luo, Wan-Yang Sun, Shu-Hua Ouyang, Yan-Ping Wu, Wen-Jun Duan, Lei Liang, Yun-Feng Cao, Xin-Xin Sun, Mei-Jing Liu, Gen-Long Jiao, Hua-Jun Wang, Hiroshi Kurihara, Xiao-Gang Wang, Rong-Rong He, Yi-Fang Li   +20 more
semanticscholar   +1 more source

Cytokine-scavenging nanodecoys reconstruct osteoclast/osteoblast balance toward the treatment of postmenopausal osteoporosis

Science Advances, 2021
Biomimetic nanodecoys reconstruct the osteoclast/osteoblast balance to treat postmenopausal osteoporosis.
Yang Zhou, Yekun Deng, Zhongmin Liu, Mengyuan Yin, Mengying Hou, Zi-Yin Zhao, Xiao-Zhong Zhou, Li-Chen Yin   +7 more
semanticscholar   +1 more source

Exosomal hsa_circ_0006859 is a potential biomarker for postmenopausal osteoporosis and enhances adipogenic versus osteogenic differentiation in human bone marrow mesenchymal stem cells by sponging miR-431-5p

Stem cell research & therapeutics, 2021
As one of the most common chronic diseases in the world, osteoporosis occurs especially in postmenopausal women. Circular RNAs (circRNAs) are emerging as major drivers in human disease.
Feng Zhi, Yi Ding, Rong Wang, Yu-Jiao Yang, K. Luo, F. Hua   +5 more
semanticscholar   +1 more source

Association of breastfeeding and postmenopausal osteoporosis in Chinese women: a community-based retrospective study

BMC Women's Health, 2019
Background Postmenopausal osteoporosis (PMOP) has long been a pervasive public health concern. With the aging Chinese population, the prevention, assessment and management of postmenopausal osteoporosis were particularly important.
Guiming Yan, Yaqi Huang, Hong Cao, Jie Wu, Nan Jiang, Xiaona Cao   +5 more
doaj   +1 more source

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update.

Journal of Clinical Endocrinology and Metabolism, 2020
OBJECTIVE The objective is to provide an update of the 2019 Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline for the pharmacological management of osteoporosis in postmenopausal women ...
Dolores M. Shoback, C. Rosen, D. Black, Angela M. Cheung, M. Murad, R. Eastell   +5 more
semanticscholar   +1 more source